close
close

Considered a Silent Epidemic, 3rd HWG G20 to Discuss Antibiotic Resistance Due to Microbes

Considered a Silent Epidemic, 3rd HWG G20 to Discuss Antibiotic Resistance Due to Microbes

JAKARTA – Indonesian G20 spokesperson Siti Nadia Tarmizi said the issue of antimicrobial resistance (AMR) or antibiotic resistance due to the impact of microbial evolution will be discussed in the order of day of the 3rd Health Working Group (HWG).

The agenda ran from August 22 to 24. The implementation is a series of Indonesia’s G20 presidency which is expected to be held in Bali.

“At the 3rd HWG, there will be a complementary agenda that will discuss AMR, namely various efforts related to the prevention and implementation of antibiotic resistance control,” said Siti, who is also Secretary of the General Directorate of Public Health of the Ministry of Health. a virtual “Road to 3rd HWG” press conference attended via Zoom on Thursday, August 18.

Confirmed separately, YARSI University Postgraduate Program Director, Professor Tjandra Yoga Aditama, added that antimicrobial resistance is a major problem in the world today. In fact, he says, we could call it a silent epidemic.

“If there are not adequate efforts, the world could enter an era where antimicrobials, including antibiotics, antifungals, antivirals, antiparasitics and others, will no longer be effective in treating infections in the world,” he said.

If this is allowed, Tjandra continued, it will have a very significant impact on human health, because infectious diseases will become more and more endemic without control, because they cannot be cured.

Meanwhile, the agenda of the 3rd HWG in Bali raised the main issue for discussion regarding efforts to increase vaccine production and manufacturing research networks.

The activity was divided into four sessions. First, efforts to create research and manufacturing networks in G20 countries related to public health emergencies.

The second session focused on efforts to strengthen research and manufacturing networks to deal with future pandemics. The third session, the involvement of government and the private sector in supporting research and manufacturing networks.

The final session discussed G20 initiatives to strengthen the research and manufacturing ecosystem to ensure equitable access to vaccines, medicines and diagnostic tools in terms of access, research and development.

The activity brought together delegates from 19 G20 and non-G20 countries. In addition, five representative countries from the region, such as Fiji, Congo, Cambodia, Rwanda and Belize, as well as 14 relevant international organizations were also invited.

Tag: kementerian kesehatan g20 endemik